Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2

被引:46
作者
Han, SH
Kim, JH
Seo, HS
Martin, MH
Chung, GH
Michalek, SM
Nahm, MH
机构
[1] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Oral Biol, Birmingham, AL 35294 USA
[4] Int Vaccine Inst, Seoul, South Korea
关键词
D O I
10.4049/jimmunol.176.1.573
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NO production by macrophages in response to lipoteichoic acid (LTA) and a synthetic lipopeptide (Pam3CSK4) was investigated. LTA and Pam3CSK4 induced the production of both TNF-alpha and NO. Inhibitors of platelet-activating factor receptor (PAFR) blocked LTA- or Pam3CSK4-induced production of NO but not TNF-alpha. Jak2 tyrosine kinase inhibition blocked LTA-induced production of NO but not TNF-alpha. PAFR inhibition blocked phosphorylation of Jak2 and STAT1, a key factor for expressing inducible NO synthase. In addition, LTA did not induce IFN-beta expression, and p38 mitogen-activated protein serine kinase was necessary for LTA-induced NO production but not for TNF-alpha production. These findings suggest that Gram-positive bacteria induce NO production using a PAFR signaling pathway to activate STAT1 via Jak2. This PAFR/jak2/STAT1 signaling pathway resembles the IFN-beta, type I IFNR/Jak/STAT1 pathway described for LPS. Consequently, Gram-positive and Gram-negative bacteria appear to have different but analogous mechanisms for NO production.
引用
收藏
页码:573 / 579
页数:7
相关论文
共 63 条
[1]   PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells [J].
Adachi, T ;
Aoki, J ;
Manya, H ;
Asou, H ;
Arai, H ;
Inoue, K .
NEUROSCIENCE LETTERS, 1997, 235 (03) :133-136
[2]   Differential expression of platelet-activating factor acetylhydrolase in macrophages and monocyte-derived dendritic cells [J].
Al-Darmaki, S ;
Schenkein, HA ;
Tew, JG ;
Barbour, SE .
JOURNAL OF IMMUNOLOGY, 2003, 170 (01) :167-173
[3]   Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist [J].
Albert, DH ;
Magoc, TJ ;
Tapang, P ;
Luo, GJ ;
Morgan, DW ;
Curtin, M ;
Sheppard, GS ;
Xu, LH ;
Heyman, HR ;
Davidsen, SK ;
Summers, JB ;
Carter, GW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 325 (01) :69-80
[4]   Regulation of platelet-activating factor synthesis in human neutrophils by MAP kinases [J].
Baker, PRS ;
Owen, JS ;
Nixon, AB ;
Thomas, LN ;
Wooten, R ;
Daniel, LW ;
O'Flaherty, JT ;
Wykle, RL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2002, 1592 (02) :175-184
[5]   Administration of the nitric oxide synthase inhibitor NG-Methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis:: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002) [J].
Bakker, J ;
Grover, R ;
McLuckie, A ;
Holzapfel, L ;
Andersson, J ;
Lodato, R ;
Watson, D ;
Grossman, S ;
Donaldson, J ;
Takala, J .
CRITICAL CARE MEDICINE, 2004, 32 (01) :1-12
[6]   Linking Toll-like receptors to IFN-α/β expression [J].
Barton, GHM ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2003, 4 (05) :432-433
[7]   Immunomodulation of pneumococcal pulmonary infection with NG-monomethyl-L-arginine [J].
Bergeron, Y ;
Ouellet, N ;
Simard, M ;
Olivier, M ;
Bergeron, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (09) :2283-2290
[8]   ACUTE CIRCULATORY COLLAPSE CAUSED BY PLATELET-ACTIVATING FACTOR (PAF-ACETHER) IN DOGS [J].
BESSIN, P ;
BONNET, J ;
APFFEL, D ;
SOULARD, C ;
DESGROUX, L ;
PELAS, I ;
BENVENISTE, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 86 (3-4) :403-413
[9]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[10]   Science, medicine, and the future - Pathogenesis of sepsis: new concepts and implications for future treatment [J].
Bochud, PY ;
Calandra, T .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7383) :262-266